Novo Nordisk (China) Pharmaceuticals Co., Ltd.

Novo Nordisk (China) Pharmaceuticals Co., Ltd.

Novo Nordisk A/S is a biopharmaceutical company founded in 1923. Having always been committed to innovation, it is a leader in the field of diabetes. The Company is headquartered in Copenhagen, Denmark, and its products are sold in more than 170 countries and regions. The Tianjin plant of Novo Nordisk (China) Pharmaceutical Co., Ltd. was established in 1995 and settled in TEDA in 2002. It successively completed large-scale expansions in 2004 and 2008. At present, the Company has two production divisions in TEDA, with a total coverage of nearly 130,000 square meters. It has become Novo Nordisk’s only supplier of durable insulin injection device in the world, and an important insulin preparation and filling production base, taking an important strategic position in the Company’s business in the Asia Pacific region.

Shall not be reproduced without permission：ZHLL.COM » Novo Nordisk (China) Pharmaceuticals Co., Ltd.